The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options
Crossref DOI link: https://doi.org/10.1007/s10555-022-10066-y
Published Online: 2022-10-14
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Yating
Tang, Shou-Ching http://orcid.org/0000-0001-5535-4453
Text and Data Mining valid from 2022-10-14
Version of Record valid from 2022-10-14
Article History
Received: 16 August 2022
Accepted: 29 September 2022
First Online: 14 October 2022
Declarations
:
: N/A
: The authors declare no competing interests.